Citigroup Raises PT on Varian Medical Systems to $71

Symbols: VAR
Tags: Citigroup
Share

Citigroup has raised the price target on Varian Medical Systems (NYSE: VAR) from $62 to $71 and maintains its Neutral rating.


 
 
< Previous
Morgan Stanley Upgrades Hologic to Overweight
Next >
Credit Suisse Downgrades Cooper Industries to Neutral
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust